Head-To-Head Survey: Neogen (NEOG) & VWR (VWR)

Neogen (NASDAQ: NEOG) and VWR (NASDAQ:VWR) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk and profitability.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Neogen and VWR, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen 0 4 0 0 2.00
VWR 0 2 1 0 2.33

Neogen presently has a consensus target price of $61.33, indicating a potential upside of 3.74%. VWR has a consensus target price of $29.00, indicating a potential downside of 12.78%. Given Neogen’s higher possible upside, research analysts plainly believe Neogen is more favorable than VWR.

Valuation and Earnings

This table compares Neogen and VWR’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Neogen $361.59 million 8.42 $43.79 million $1.01 58.82
VWR $4.51 billion 0.97 $148.20 million $1.14 29.17

VWR has higher revenue and earnings than Neogen. VWR is trading at a lower price-to-earnings ratio than Neogen, indicating that it is currently the more affordable of the two stocks.


This table compares Neogen and VWR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Neogen 13.47% 10.72% 9.57%
VWR 4.11% 11.79% 3.67%

Insider and Institutional Ownership

64.5% of Neogen shares are held by institutional investors. Comparatively, 96.7% of VWR shares are held by institutional investors. 4.2% of Neogen shares are held by company insiders. Comparatively, 35.5% of VWR shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.


VWR beats Neogen on 8 of the 13 factors compared between the two stocks.

Neogen Company Profile

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products dedicated to animal health, including a range of consumable products marketed to veterinarians and animal health product distributors. The Animal Safety segment also provides genetic identification services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.

VWR Company Profile

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC. The Americas segment consists of operations located principally in the United States and Canada, as well as in Puerto Rico, Mexico and select countries in Central and South America, including Costa Rica, Brazil, Argentina and Chile. As of December 31, 2016, the Americas segment included 67 facilities located in eight countries. As of December 31, 2016, the EMEA-APAC segment consisted of its operations located principally in Europe, as well as in certain Asia-Pacific countries, and included 110 facilities located in 26 countries. The Company’s portfolio includes chemicals, reagents, consumables, durable products and scientific equipment and instruments.

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit